These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 26684170

  • 1. The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.
    Costacou T, Orchard TJ.
    J Diabetes Complications; 2016 Mar; 30(2):221-6. PubMed ID: 26684170
    [Abstract] [Full Text] [Related]

  • 2. Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.
    Costacou T, Secrest AM, Ferrell RE, Orchard TJ.
    Diab Vasc Dis Res; 2014 Sep; 11(5):335-42. PubMed ID: 24994788
    [Abstract] [Full Text] [Related]

  • 3. Hypothesis--haptoglobin genotype and diabetic nephropathy.
    Nakhoul FM, Miller-Lotan R, Awaad H, Asleh R, Levy AP.
    Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716
    [Abstract] [Full Text] [Related]

  • 4. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
    Dalan R, Liuh Ling G.
    Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
    [Abstract] [Full Text] [Related]

  • 5. Haptoglobin genotype and renal function decline in type 1 diabetes.
    Costacou T, Ferrell RE, Ellis D, Orchard TJ.
    Diabetes; 2009 Dec; 58(12):2904-9. PubMed ID: 19720796
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V, Theilade S, Winther SA, Tofte N, Eugen-Olsen J, Persson F, Hansen TW, Jeppesen J, Rossing P.
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [Abstract] [Full Text] [Related]

  • 8. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes.
    Tynjälä A, Forsblom C, Harjutsalo V, Groop PH, Gordin D, FinnDiane Study Group.
    Diabetes Care; 2020 Sep; 43(9):2266-2271. PubMed ID: 32647049
    [Abstract] [Full Text] [Related]

  • 9. Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes.
    Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P.
    Diabet Med; 2012 Aug; 29(8):990-4. PubMed ID: 22414297
    [Abstract] [Full Text] [Related]

  • 10. Haptoglobin genotype and risk of diabetic nephropathy in patients with type 1 diabetes mellitus: a study on a Spanish population.
    Amor AJ, Canivell S, Oriola J, Ricart MJ, de Hollanda AM, Bosch-Comas A, Esmatjes E.
    Nefrologia; 2014 Aug; 34(2):212-5. PubMed ID: 24658196
    [Abstract] [Full Text] [Related]

  • 11. The haptoglobin 2-2 genotype is associated with cardiac autonomic neuropathy in type 1 diabetes: the RETRO HDLc study.
    Ju J, Tomaszewski EL, Orchard TJ, Evans RW, Feingold E, Costacou T.
    Acta Diabetol; 2020 Mar; 57(3):271-278. PubMed ID: 31529337
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial.
    Jhund PS, McMurray JJ, Chaturvedi N, Brunel P, Desai AS, Finn PV, Haffner SM, Solomon SD, Weinrauch LA, Claggett BL, Pfeffer MA.
    Eur Heart J; 2015 Sep 21; 36(36):2463-9. PubMed ID: 26188211
    [Abstract] [Full Text] [Related]

  • 14. Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
    Velho G, El Boustany R, Lefèvre G, Mohammedi K, Fumeron F, Potier L, Bankir L, Bouby N, Hadjadj S, Marre M, Roussel R.
    Diabetes Care; 2016 Dec 21; 39(12):2288-2295. PubMed ID: 27729425
    [Abstract] [Full Text] [Related]

  • 15. Association between haptoglobin gene variants and diabetic nephropathy: haptoglobin polymorphism in nephropathy susceptibility.
    Conway BR, Savage DA, Brady HR, Maxwell AP.
    Nephron Exp Nephrol; 2007 Dec 21; 105(3):e75-9. PubMed ID: 17220636
    [Abstract] [Full Text] [Related]

  • 16. Does the Concentration of Oxidative and Inflammatory Biomarkers Differ by Haptoglobin Genotype in Type 1 Diabetes?
    Costacou T, Evans RW, Orchard TJ.
    Antioxid Redox Signal; 2015 Dec 20; 23(18):1439-44. PubMed ID: 26114833
    [Abstract] [Full Text] [Related]

  • 17. Haptoglobin phenotype and vascular complications in patients with diabetes.
    Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, Skorecki K.
    N Engl J Med; 2000 Sep 28; 343(13):969-70. PubMed ID: 11012324
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
    Nakhoul FM, Miller-Lotan R, Awad H, Asleh R, Jad K, Nakhoul N, Asaf R, Abu-Saleh N, Levy AP.
    Am J Physiol Renal Physiol; 2009 Apr 28; 296(4):F830-8. PubMed ID: 19176700
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.